Follow the Alkem Laboratories Limited share price and the full directors' dealings record of the company, a listed issuer based in India. Shares are listed on IN IN, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Alkem Laboratories Limited has published 23 insider filings. Market capitalisation: €583.7bn. The latest transaction was disclosed on 29 March 2022 (Sale). Among the most active insiders: Deepak Kumar Singh. All data is free.
23
Insider Decl.
0
Thresholds
€306,892
12 ops.
Buy Volume
€3m
11 ops.
Sell Volume
10Σ signal
Buys €306,892€3m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 7,698 of 26,127 companies
61.6
score / 100
Value
42
Quality
81
FCF yld2.0%
Earn yld3.4%
EV/EBITDA20.4x
ROE18%
Gross mgn65%
Net mgn16%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.